Your browser doesn't support javascript.
loading
Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
Bastiaens, Guido J H; Tiono, Alfred B; Okebe, Joseph; Pett, Helmi E; Coulibaly, Sam A; Gonçalves, Bronner P; Affara, Muna; Ouédraogo, Alphonse; Bougouma, Edith C; Sanou, Guillaume S; Nébié, Issa; Bradley, John; Lanke, Kjerstin H W; Niemi, Mikko; Sirima, Sodiomon B; d'Alessandro, Umberto; Bousema, Teun; Drakeley, Chris.
Afiliação
  • Bastiaens GJH; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Tiono AB; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Okebe J; Disease Control & Elimination Theme, Medical Research Council Unit, Fajara, The Gambia.
  • Pett HE; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Coulibaly SA; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Gonçalves BP; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Affara M; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Ouédraogo A; Disease Control & Elimination Theme, Medical Research Council Unit, Fajara, The Gambia.
  • Bougouma EC; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Sanou GS; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Nébié I; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Bradley J; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Lanke KHW; MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Niemi M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Sirima SB; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • d'Alessandro U; Department of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Bousema T; Disease Control & Elimination Theme, Medical Research Council Unit, Fajara, The Gambia.
  • Drakeley C; Department of Disease Control, Faculty of infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
PLoS One ; 13(1): e0190272, 2018.
Article em En | MEDLINE | ID: mdl-29324864
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Primaquina / Malária Falciparum / Glucosefosfato Desidrogenase / Antimaláricos Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Primaquina / Malária Falciparum / Glucosefosfato Desidrogenase / Antimaláricos Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article